These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8424824)

  • 1. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin.
    Rankin SM; de Whalley CV; Hoult JR; Jessup W; Wilkins GM; Collard J; Leake DS
    Biochem Pharmacol; 1993 Jan; 45(1):67-75. PubMed ID: 8424824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages.
    de Whalley CV; Rankin SM; Hoult JR; Jessup W; Leake DS
    Biochem Pharmacol; 1990 Jun; 39(11):1743-50. PubMed ID: 2344371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.
    Hoff HF; O'Neil J
    Atherosclerosis; 1988 Mar; 70(1-2):29-41. PubMed ID: 3355615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation.
    Chen JH; Tsai CW; Wang CP; Lin HH
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):313-24. PubMed ID: 23845592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages.
    Jessup W; Mander EL; Dean RT
    Biochim Biophys Acta; 1992 Jun; 1126(2):167-77. PubMed ID: 1627619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.
    Lian TW; Wang L; Lo YH; Huang IJ; Wu MJ
    Biochim Biophys Acta; 2008 Oct; 1781(10):601-9. PubMed ID: 18662803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat C-reactive protein causes a charge modification of LDL and stimulates its degradation by macrophages.
    Mookerjea S; Francis J; Hunt D; Yang CY; Nagpurkar A
    Arterioscler Thromb; 1994 Feb; 14(2):282-7. PubMed ID: 8305421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.
    Hazell LJ; Stocker R
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):165-72. PubMed ID: 8439285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid.
    Mangiapane H; Thomson J; Salter A; Brown S; Bell GD; White DA
    Biochem Pharmacol; 1992 Feb; 43(3):445-50. PubMed ID: 1540202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
    Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
    Henriksen T; Mahoney EM; Steinberg D
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6499-503. PubMed ID: 6273873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids.
    Myara I; Pico I; Vedie B; Moatti N
    J Pharmacol Toxicol Methods; 1993 Oct; 30(2):69-73. PubMed ID: 8298183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of a high-affinity heparin subfraction with low-density lipoprotein stimulates cholesteryl ester accumulation in mouse macrophages.
    Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1991 Jan; 1081(2):188-96. PubMed ID: 1998737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of copper-binding sites on low density lipoprotein.
    Roland A; Patterson RA; Leake DS
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):594-602. PubMed ID: 11304478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro.
    Samadi-Baboli M; Favre G; Bernadou J; Berg D; Soula G
    Biochem Pharmacol; 1990 Jul; 40(2):203-12. PubMed ID: 2375762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of natural polyphenol compounds on the oxidative modification of low-density lipoproteins].
    Dushkin MI; Zykov AA; Pivovarova EN
    Biull Eksp Biol Med; 1993 Oct; 116(10):393-5. PubMed ID: 8117961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-associated cholesteryl esters by J774 macrophages.
    Rinninger F; Greten H
    Biochim Biophys Acta; 1990 Apr; 1043(3):318-26. PubMed ID: 2157492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N; Triggle DJ
    Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative microscopic and biochemical study of the uptake of fluorescent and 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture.
    Reynolds GD; St Clair RW
    Am J Pathol; 1985 Nov; 121(2):200-11. PubMed ID: 3840653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.